VYCOR MEDICAL INC
VYCOUS売上高
$2M
百万USD
営業利益
$0M
百万USD
純利益
$-0M
百万USD
ROE
1.8%
最新FY
EPS
$-0.01
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $0M | $-0M | - |
| FY2021 | Q2 | $0M | $-0M | - |
| FY2021 | Q3 | $0M | $0M | - |
| FY2021 | FY | $1M | $-0M | - |
| FY2022 | Q1 | $0M | $-0M | - |
| FY2022 | Q2 | $0M | $-0M | - |
| FY2022 | Q3 | $0M | $-0M | - |
| FY2022 | FY | $1M | $-0M | - |
| FY2023 | Q1 | $0M | $0M | - |
| FY2023 | Q2 | $0M | $0M | $0.00 |
| FY2023 | Q3 | $0M | $-0M | $-0.01 |
| FY2023 | FY | $1M | $-0M | $-0.01 |
| FY2024 | Q1 | $0M | $-0M | $-0.01 |
| FY2024 | Q2 | $0M | $-0M | $0.00 |
| FY2024 | Q3 | $0M | $-0M | $-0.01 |
| FY2024 | FY | $2M | $-0M | $-0.01 |
| FY2025 | Q1 | $0M | $-0M | $-0.01 |
| FY2025 | Q2 | $0M | $0M | $0.00 |
| FY2025 | Q3 | $1M | $0M | $0.00 |
| FY2025 | FY | $2M | $-0M | $-0.01 |
| FY2026 | Q1 | $0M | $0M | $0.00 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M |
| 営業利益 | $-2M | $-1M | $-1M | $-1M | $-1M | $-0M | $-0M | $0M | $-0M | $0M |
| 純利益 | $-2M | $-1M | $-1M | $-1M | $-1M | $-0M | $-0M | $-0M | $-0M | $-0M |
| 総資産 | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $-0M | $0M | $-1M | $-1M | $-2M | $-2M | $-3M | $-3M | $-4M | $-4M |
| 営業CF | $-0M | $-1M | $-0M | $0M | $-0M | $0M | $-0M | $0M | $0M | $-0M |
| EPS | - | - | - | - | - | - | - | $-0.01 | $-0.01 | $-0.01 |
| BPS | $-0.00 | $0.00 | $-0.03 | $-0.05 | $-0.07 | $-0.08 | $-0.09 | $-0.10 | $-0.11 | $-0.12 |
| ROE | 6249.6% | -1813.6% | 179.4% | 58.8% | 41.5% | 18.2% | 13.8% | 2.1% | 2.9% | 1.8% |